Restricted accessResearch articleFirst published online 2004-7
Characteristics and Outcomes of Patients Bridged to Cardiac Transplantation on Centrifugal Ventricular Assist Devices: A Case Series of the Early Experience of One Canadian Transplant Centre
Background: Centrifugal ventricular assist devices (VADs) have been used successfully to bridge patients in cardiogenic shock to cardiac transplantation, though complications are frequent and often life-threatening. Purpose: To describe characteristics and examine outcomes of patients bridged to cardiac transplantation on centrifugal VADs. Methods: A retrospective health record review was conducted on all adults over a 12 year period (N=20) placed on centrifugal VADs with the intent to bridge to cardiac transplantation at a major Canadian transplant centre. Results: Complications of VAD support necessitated removal of 12 patients from the transplant list; seven (35%) survived to cardiac transplantation. Of the seven recipients, five survived to discharge and four remain alive and well. Conclusions: Bridging patients on centrifugal VADs to cardiac transplantation requires improvement, including maintaining patient stability during the period of early VAD institution, aggressively managing complications of VAD support, and consideration of long-term pulsatile devices. However, if patients survive to transplantation, good long-term outcomes are expected.
Cooley D.Mechanical circulatory support systems: past, present, and future.Ann Thorac Surg. 1999;68:641-642
2.
Dembitsky W.Bridging from acute to chronic devices.Ann Thorac Surg. 1999;68:724-728
3.
Deng M,Edwards L,Hertz M,Rowe A,Kormos R.Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: first annual report—2003.J Heart Lung Transplant. 2003;22:653-662
4.
Vitali E,Lanfranconi M,Bruschi G,Russo C,Colombo T,Ribera E.Left ventricular assist devices as bridge to heart transplantation: the Niguarda experience.J Cardiac Surg. 2003;18:107-113
5.
El-Banayosy A,Korfer R,Arusoglu L,Minami K,Kizner L,Fey O, et al.Bridging to cardiac transplantation with the thoratec ventricular assist device.Thorac Cardiovasc Surg. 1999;47 (Suppl 2): 307-310
6.
Hendry P,Masters R,Davies R,Mesana T,Struthers C,Mussivand T, et al.Mechanical circulatory support for adolescent patients: the Ottawa Heart Institute experience.Can J Cardiol. 2003;19:409-412
7.
Vitali E,Lanfranconi M,Ribera E,Bruschi G,Colombo T,Frigerio M, et al.Successful experience in bridging patients to heart transplantation with the MicroMed DeBakey ventricular assist device.Ann Thorac Surg. 2003;75:1200-1204
8.
Christiansen S,Van Aken H,Breithardt G,Scheld H,Hammel D.Successful cardiac transplantation after 4 cases of DeBakey left ventricular assist device failure.J Heart Lung Transplant. 2002;21:706-709
9.
Scherr K,Jensen L,Koshal A.Mechanical circulatory support as a bridge to cardiac transplantation: Toward the 21st century.Am J Crit Care. 1999;8:324-339
10.
Aaronson K,Eppinger M,Dyke D,Wright S,Pagani F.Left ventricular assist device therapy improves utilization of donor hearts.J Am Coll Cardiol. 2002;39:1247-1254
11.
Wang S,Ko W,Chen Y,Hsu R,Chou N,Chu S.Mechanical bridge with extracorporeal membrane oxygenation and ventricular assist device to heart transplantation.Artif Organs. 2001;25:599-602
12.
McCarthy J,McCarthy P,Massad M,Cook D,Smedira N,Kasirajan V, et al.Risk factors for death after heart transplantation: Does a single-center experience correlate with multicenter registries?.Ann Thorac Surg. 1998;65:1574-1578
13.
Agati S,Bruschi G,Russo C,Colombo T,Lanfranconi M,Vitali E.First successful Italian clinical experience with DeBakey VAD.J Heart Lung Transplant. 2001;20:914-917
14.
Quaini E,Pavie A,Chieco S,Mambrito B.The concerted action heart european registry on clinical application of mechanical circulatory support systems: bridge to transplant. The registry scientific committee.Euro J Cardio-Thorac Surg. 1997;11:182-188
15.
Chen Y,Ko W,Lin F,Huang S,Chou T, et al.Preliminary result of an algorithm to select proper ventricular assist devices for high-risk patients with extracorporeal membrane oxygenation support.J Heart Lung Transplant. 2001;20:850-857
16.
Bowen R,Carboni A,O'Hara M,Pochettino A,Rosengard B, et al.Application of ‘double bridge mechanical’ resuscitation for profound cardiogenic shock leading to cardiac transplantation.Ann Thorac Surg. 2001;72:86-90
17.
Nose Y,Yoshikawa M,Murabayashi S,Takano T.Artif Organs. 2000;24:412-420
18.
Jaski B,Kim J,Naftel D,Jarcho J,Costanzo M, et al.Cardiac transplant outcome of patients supported on left ventricular assist device vs. intravenous inotropic therapy.J Heart Lung Transplant. 2001;20:449-456
19.
El-Banayosy A,Korfer R,Arusoglu L,Kizner L,Morshuis M, et al.Device and patient management in a bridge-to-transplant setting.Ann Thorac Surg. 2001;71:S98-S102
20.
Farrar, D..Thoratec Ventricular Assist Device Principal Investigators. Preoperative predictors of survival in patients with thoratec ventricular assist devices as a bridge to heart transplantation.J Heart Lung Transplant. 1994;13:93-100
21.
Hoy F,Mueller D,Geiss D,Munns J,Bond L, et al.Bridge to recovery for postcardiotomy failure: Is there still a role for centrifugal pumps?.Ann Thorac Surg. 2000;70:1259-1263
22.
Pennington D,Oaks T,Lohmann D.Permanent ventricular assist device support vs. cardiac transplantation.Ann Thorac Surg. 1999;68:729-733
23.
Kirsch M,Baufreton C,Naftel D,Benvenuti C,Loisance D.Pretransplantation risk factors for death after heart transplantation: the Henri Mondor experience.J Heart Lung Transplant. 1998;17:268-277
24.
Magovern G.The biopump and postoperative circulatory support.Ann Thorac Surg. 1993;55:245-249
25.
Sapirstein J,Pae W,Aufiero T,Boehmer J,Pierce W.Long-term ventricular assist device use before transplantation.ASAIO J. 1995;41:M530-M534
Tenderich G,Arusoglu L,El-Banayosy A,Morshuis M,Mirow N, et al.Influence of different assist devices on survival after orthotopic heart transplantation.Int J Artif Organs. 1999;22:764-768
28.
Pae W,Miller C,Matthews Y,Pierce W.Ventricular assist devices for postcardiotomy cardiogenic shock: a combined registry experience.J Thorac Cardiovasc Surg. 1992;104:541-553
29.
Letsou G,Myers T,Gregoric E,Delgado R,Shah N, et al.Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months.Ann Thorac Surg. 2003;76:1167-1170
30.
Deng M,Weyand M,Hammel D,Schmid C,Kerber S, et al.Selection and management of ventricular assist device patients: the Muenster experience.J Heart Lung Transplant. 2000;19:S77-S82
31.
Ashton R,Goldstein D,Rose E,Weinberg A,Levin H,Oz M.Duration of left ventricular assist device support affects transplant survival.J Heart Lung Transplant. 1996;15:1151-1157
32.
Magliato K,Kleisli T,Soukiasian H,Tabrizi R,Coleman B, et al.Biventricular support in patients with profound cardiogenic shock: a single center experience.ASAIO J. 2003;49:475-479
33.
Miller L.Patient selection for the use of ventricular assist devices as a bridge to transplantation.Ann Thorac Surg. 2003;75:S66-S71
34.
McBride L,Naunheim K,Fiore A,Johnson R,Moroney D, et al.Risk analysis in patients bridged to transplantation.Ann Thorac Surg. 2001;71:1839-1844
35.
Pagani R,Lynch W,Swaniker F,Dyke D,Bartlett R, et al.Extracorporeal life support to left ventricular assist device bridge to heart transplant: a strategy to optimize survival and resource utilization.Circulation. 1999;100:SII206-SII210
36.
Ashton R,Goldstein D,Rose E,Weinberg A,Levin H,Oz M.Duration of left ventricular assist device support affects transplant Survival.J Heart Lung Transplant. 1996;15:1151-1157
37.
Pierce W,Hershon J,Kormos R,Dembitsky W,Noon G.Management of secondary organ dysfunction.Ann Thorac Surg. 1993;55:222-226
38.
Masters R,Hendry P,Davies R,Smith S,Struthers C,Walley V, et al.Cardiac transplantation after mechanical circulatory support: a canadian perspective.Ann Thorac Surg. 1996;61:1734-1739
39.
Reiss N,El-Banayosy A,Mirow N,Minami K,Korfer R.Implantation of the Biomedicus centrifugal pump in post-transplant right heart failure.J Cardiovasc Surg. 2000;41:691-694
40.
Herrmann M,Weyand M,Greshake B,von Eiff C,Proctor R,Scheld H, et al.Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation.Circulation. 1997;95:814-817
41.
Fischer S,Trenholme G,Costanzo M,Piccione W.Infectious complications in left ventricular assist device recipients.Clin Infect Disease. 1997;24:18-23.42
42.
Rickenbacher P,Hunt SHandbook of cardiac transplantation. Emery RMiller L, ed. St. Louis: Mosby; 1996:201-216.
